Dissimilar effects of cisplatin and the pyridopyrazolo-pyrimidine derivative KP972 on free radicals

Advances in Clinical and Experimental Medicine

Volumn 18, Issue 6, 2009, Pages 551-557

  Sawicka, E W A ^a   Długosz, Anna ^a   Porȩba, Krystyna ^a   Chowaniec, Agata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antiproliferative effect; Cisplatin; Hydroxyl radical; KP972; Lipid peroxidation

Indexed keywords

ANTIMITOTIC AGENT; CISPLATIN; DEOXYRIBOSE; FREE RADICAL; HYDROXYL RADICAL; KP 972; MALONALDEHYDE; PYRAZOLOPYRIMIDINE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME DEGRADATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; MITOCHONDRION; PLACENTA; URINE;

EID: 76249119797     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cerutti PA: Oxy-radicals and cancer. Lancet 1994, 24, 344, 862-863.
2. Guyton K, Hensler T: Oxidative mechanisms in carcinogenesis. Br Med Bull 1993, 523-544.
3. Singh KK: Oxidative stress, disease and cancer. Eds.: Roswell Park Cancer Institute, Imperial College Press, New York, USA 2006, 705-731, 1013-1022.
4. Sun Y: Free radicals, antioxidants enzymes, and carcinogenesis. Free Radic Biol Med 1990, 8, 583-599.
5. Jung-Whan K, Chi VD: Cancer's Molecular Sweet Tooth and the Warburg Effect. Cancer Res 2006, 66, 15, 8927-8930.
6. Stocks J, Offerman EL, Model CB, Dormandy TL: The susceptibility to autooxidation of human red cell lipids in health and disease. Br J Haematol 1972, 23, 713-724.
7. Rice-Evans C, Burdon R: Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993, 32, 1, 71-110.
8. Lowry OH, Rosenbrough JN, Farr AL, Randell R: Protein measurement with the Folin Phenol reagent. J Biol Chem 1951, 193, 265-275.
9. Lass A, Sohal R: Electron transport-linked ubiquinone-dependent recycling of α-tocoferol inhibits autooxidation of mitochondrial membranes. Arch Biochem Biophys 1998, 352(2), 229-236.
10. Radi R, Sims S, Cassina A, Turrens JR: Role of catalase and cytochrome c in hydroxyperoxide-dependent lipid peroxidation and chemiluminescence in rat heart and kidney mitochondria. Free Radic Biol Med 1993, 15, 653-659.
11. Długosz A, Piotrowska D: Lipid peroxidation stimulated by Solvesso, Bawanol and methanol, and its counteraction by antioxidants in human placental mitochondria. Toxicol in Vitro 2002, 16, 649-659.
12. Gawlik M: Zastosowanie modelu krwinki czerwonej człowieka do badania właściwości antyoksydacyjnych zwia̧zków zawartych w wodnych ekstraktach produktów spożywczych na przykładzie herbaty. Bromat Chem Toksykol XXXVII, 2004, 4, 311-316.
13. Rybak LP, Whitworth C, Somani S: Application of antioxidants and other agents to present cisplatin ototoxicity. Laryngoscope 1999, 109, 1740-1744.
14. Rybak LP, Husain K, Morris C, Whitworth C, Somani S: Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000, 21(4), 513-520.
15. Chirino YI, Sanchez-Gonzalez DJ, Matrinez-Martinez CM, Cruz C, Pedraza-Chaverri J: Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008, 245 (1-2), 18-23.
16. Youngke L, Cederbaum AI: Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 2005, 89 (2), 515-523.
17. Santos NAG, Martins N: Dimethylthiourea protects against mitochondrial oxidative damage induced by cispla-tin in liver of rats. Chem-Biol Interact 2007, 170, (3), 177-186.
18. Santos NAG, Bezerra CSC, Martins NM, Curti C, Bianchi MLP, Santos AC: Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother Pharmacol 2008, 6, 145-155.
19. Zhou H, Kato A, Miyaji T, Yasuda H, Fujigaki Y, Yamamoto T, Yonemura K, Takebayashi S, Mineta H, Hishida A: Urinary marker of oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol Dial Transplant 2006, 21, 616-623.
20. Siomek A, Oliński R, Tujakowski J: Severe oxidatively damaged DNA after cisplatin treatment of cancer patients, Int J Cancer 2006, 119, 2228-2230.
21. Yuce A, Atessahin A, Ceribas AO, Akasakal M: Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharmacol Toxicol 2007, 101, 345-349.
22. Porȩba K, Opolski A, Wietrzyk J, Kowalska M: Synthesis and antiproliferative activity in vitro of new derivatives of 3-aminopyrazolo[3,4-b]pyridine. Arch Pharm Pharm Med Chem 2001, 334, 219-223.
23. Wolin RM, Afonio A, Kelly JM, Njorge FG: Pat. USA 5595998, 1997; C.A. 126, 199793j, 1997.